Is There a Role for Probiotics in Helicobacter pylori Therapy?

Area of Science:

• Microbiology
• Gastroenterology
• Pharmacology

Background:

• The efficacy of probiotics as an adjunct to standard therapy for Helicobacter pylori (H. pylori) eradication remains under investigation.
• Certain Lactobacilli strains exhibit in vitro inhibitory effects against H. pylori, suggesting potential therapeutic applications.

Purpose of the Study:

• To evaluate the current evidence on the role of probiotics in H. pylori treatment regimens.
• To identify the need for further research into specific probiotic strains and their optimal usage.

Main Methods:

• Systematic review and analysis of existing clinical trials on probiotics for H. pylori infection.
• In vitro studies examining the antimicrobial activity of Lactobacilli against H. pylori.

Main Results:

• No definitive evidence supports a significant increase in H. pylori eradication rates when probiotics are added to conventional treatment.
• Promising preliminary results exist for specific strains like Lactobacillus reuteri and Saccharomyces boulardii.

Conclusions:

• High-quality clinical trials are required to establish the definitive role of probiotics as adjuvant therapy for H. pylori.
• Further research on Lactobacillus reuteri should focus on optimizing dosage, frequency, timing, and duration of administration.